See also this year's filing and all EDGAR filings for this company.
PDF Report 0001445815_2023_Bioxytran_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 3820147, 'size_variable': 'Assets', 'size_value': 137638, 'ratio': 27.8, 'threshold': 20} |
Graph
Absolute values for 0001445815, Bioxytran INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 295,401 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 75,535 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,663,482 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 904,292 |
| 9 | ResearchAndDevelopmentExpense | 977,768 |
| 10 | remainder_Expenses | 224,555 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -449,311 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 370,936 |
| 1 | Liabilities | 3,663,482 |
| 2 | Expenses | 2,106,615 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,292,546 |
| 5 | NetIncome | -2,555,926 |
| 6 | ComprehensiveNetIncome | -2,555,926 |
| 7 | BaseVar | 3,295,172 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.83 |
| 9 | EconomicCapitalRatio | 0.219 |
Edgar->Model Mapping
Feature Distribution
Change over Time
